The Ideal Diet A phase 3 double-blinded, randomized clinical control trial published in 2022 that looked at the use of a GLP-1 agonist, Tirzepatide (Mounjaro ), for the treatment of obesity has paved the way for the use of GLP-1 agonists for weight loss (1)
Its easy to schedule a free consultation and ask all of your questions
Plans starting at $179/month Get your affordable weight loss program Doctor personalized plans, just for you Lose up to 25% of your weight All inclusive pricing Summer sale
Weekly usage: 14 swabs (2 per day) 8 weeks: 112 swabs recommended 2 boxes (100-count each) 12 weeks: 168 swabs recommended 2 boxes (100-count each) 16 weeks: 224 swabs recommended 3 boxes (100-count each) Protocol Overview Goal: Support recovery, tissue regeneration, and inflammation control Schedule: Daily injections for 812 weeks Approach: Gradual dose escalation, then maintenance phase Reconstitution: 3.0 mL per vial for accurate dosing Storage: Refrigerated after mixing Dosing Protocol A consistent once-daily dosing structure designed for balanced peptide administration
Weight loss, exercise, and improved sleep produce additional reductions over 2-3 months